Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Thépot, Sylvain
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
A
Lefeuvre C
,
Thépot S
,
Mercier-Delarue S
,
Bouille T
,
Michonneau D
,
Le Goff J
,
Salmona M
.
Adenovirus F41 infection and liver cytolysis in adult hematopoietic stem cell transplant recipients.
J Med Virol. 2023;95(7):e28922.
PubMed
Google Scholar
C
Peterlin P
,
Le Bris Y
,
Turlure P
,
Chevallier P
,
Ménard A
,
Gourin M-P
,
Dumas P-Y
,
Thépot S
,
Berceanu A
,
Park S
, et al.
CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 study.
Lancet Haematol. 2023.
PubMed
Google Scholar
D
Itzykson R
,
Santini V
,
Thépot S
,
Ades L
,
Chaffaut C
,
Giagounidis A
,
Morabito M
,
Droin N
,
Lübbert M
,
Sapena R
, et al.
Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network.
J Clin Oncol. 2022:JCO2200437.
PubMed
Google Scholar
Orvain C
,
Beloncle F
,
Hamel J-F
,
Thépot S
,
Mercier M
,
Kouatchet A
,
Farhi J
,
François S
,
Guardiola P
,
Asfar P
, et al.
Different Impact of the Number of Organ Failures and Graft-Versus-Host Disease on the Outcome of Allogeneic Stem Cell Transplantation Recipients Requiring Intensive Care.
Transplantation. 2016.
PubMed
Google Scholar
E
Jullien M
,
Orvain C
,
Berceanu A
,
Couturier M-A
,
Guillaume T
,
Peterlin P
,
Garnier A
,
Le Bourgeois A
,
Klemencie M
,
Schmidt A
, et al.
Early Post-Transplant Serum Ferritin Levels Predict Survivals in Recipients of Haploidentical Stem Cell Transplantation Using PTCY as GVHD Prophylaxis.
Transplant Cell Ther. 2021.
PubMed
Google Scholar
I
Jullien M
,
Orvain C
,
Berceanu A
,
Couturier M-A
,
Guillaume T
,
Peterlin P
,
Garnier A
,
Le Bourgeois A
,
Klemencie M
,
Schmidt A
, et al.
Impact of allogeneic stem cell transplantation comorbidity indexes after haplotransplant using post-transplant cyclophosphamide.
Cancer Med. 2021.
PubMed
Google Scholar
P
Guillaume T
,
Thépot S
,
Peterlin P
,
Ceballos P
,
Le Bourgeois A
,
Garnier A
,
Orvain C
,
Giltat A
,
François S
,
Le Bris Y
, et al.
Prophylactic or preemptive low-dose azacitidine and donor lymphocyte infusion to prevent disease relapse following allogeneic transplantation in patients with high risk acute myeloid leukemia or myelodysplastic syndrome.
Transplant Cell Ther. 2021.
PubMed
Google Scholar
R
Lacombe V
,
Gomes CNunes
,
Robin J-B
,
Thépot S
,
François S
,
Cottin L
,
Ugo V
,
Dieu X
,
Abgueguen P
,
Daniel V
, et al.
Risk of infection according to the gamma globulin level in the 100 days following allogeneic stem cell transplantations.
Eur J Haematol. 2021.
PubMed
Google Scholar